Tirzepatide 10mg per Vial “TO BE ADDED SOON”

Tirzepatide 10mg per Vial

Weight Loss: It causes substantial and sustained body weight loss by suppressing appetite, promoting a feeling of fullness (satiety), and reducing overall energy intake. Patients in clinical trials experienced significant weight reductions compared to placebo.

Cardiovascular Health: Tirzepatide can lower the risk of major adverse cardiovascular events (like heart attack, stroke, or cardiovascular death) in high-risk patients with type 2 diabetes and obesity. It improves related health markers such as blood pressure and cholesterol levels.

Kidney Function: Studies have shown that it can improve markers of kidney function in patients who also have obesity and heart failure.

Treatment of Obstructive Sleep Apnea (OSA): It is also used to treat moderate to severe obstructive sleep apnea (OSA) in patients with obesity, likely through weight loss and reducing inflammation.

Improved Quality of Life: Beyond physical metrics, patients often report improved energy levels, better physical functioning, and enhanced emotional well-being due to weight loss and better health management.

Metabolic Improvements: It improves insulin sensitivity and helps manage inflammation throughout the body, addressing root causes of several chronic conditions. 

Blood Sugar Control: For individuals with type 2 diabetes, tirzepatide helps control blood glucose levels effectively by increasing insulin production and reducing the amount of sugar the liver releases into the blood. It has been shown to reduce hemoglobin A1C (HbA1C) levels significantly.